Evidence map›Paper›PMID 30282707›Full record

ArticleJournal of virology2018

Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.

Shaohui Wang, Alexander V Ljubimov, Ling Jin, Klaus Pfeffer, Mitchell Kronenberg, Homayon Ghiasi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Shaohui WangCenter for Neurobiology and Vaccine Development, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California, USA.
Alexander V LjubimovEye Program, Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center and David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Ling JinDepartment of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Klaus PfefferInstitute of Medical Microbiology, University of Düsseldorf, Dusseldorf, Germany.
Mitchell KronenbergLa Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Homayon GhiasiCenter for Neurobiology and Vaccine Development, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California, USA ghiasih@cshs.org.
Cedars-Sinai Medical Center · USHeinrich Heine University Düsseldorf · DEOregon State University · USUniversity of California, Los Angeles · USUniversity of California, San Diego · US

Funding

Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
The Role of gK in HSV-1 Induced Corneal ScarringR01EY013615 · NEI · CEDARS-SINAI MEDICAL CENTER · PI HOMAYON GHIASI · 2002 to 2026
$7.8M
Therapeutic control of HSK by CD80R01EY026944 · NEI · CEDARS-SINAI MEDICAL CENTER · PI GHIASI, HOMAYON · 2016 to 2025
$3.9M
Ocular HSV: Mechanism of virus reactivationR01EY029160 · NEI · CEDARS-SINAI MEDICAL CENTER · PI HOMAYON GHIASI · 2018 to 2026
$3.4M
HVEM: A TNF family receptor that influences mucosal immunity and the microbiomeU01AI125955 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2016 to 2020
$2.7M
NEI NIH HHS R01 EY013615NEI NIH HHS R01 EY026944NEI NIH HHS R01 EY029160NIAID NIH HHS U01 AI125955NIDDK NIH HHS P01 DK046763
6 · The paper itself

Abstract

Recently, we reported that the herpesvirus entry mediator (HVEM; also called TNFRSF14 or CD270) is upregulated by the latency-associated transcript (LAT) of herpes simplex virus 1 (HSV-1) and that the absence of HVEM affects latency reactivation but not primary infection in ocularly infected mice. gD has been shown to bind to HVEM. LIGHT (TNFSF14), CD160, and BTLA (B- and T-lymphocyte attenuator) also interact with HVEM and can interfere with HSV gD binding. It was not known if LIGHT, CD160, or BTLA affected the level of latency reactivation in the trigeminal ganglia (TG) of latently infected mice. To address this issue, we ocularly infected LIGHT

Indexed as

AnimalsAntigens, CDEye DiseasesFemaleGene Knockout TechniquesGPI-Linked ProteinsHerpes SimplexHerpesvirus 1, HumanKineticsMaleMiceMicroRNAsReceptors, ImmunologicReceptors, Tumor Necrosis Factor, Member 14Tumor Necrosis Factor Ligand Superfamily Member 14Viral Envelope ProteinsAntigens, CDBTLA protein, mouseCd160 protein, mouseglycoprotein D, Human herpesvirus 1GPI-Linked Proteinslatency associated transcript, herpes simplex virus-1MicroRNAsReceptors, ImmunologicReceptors, Tumor Necrosis Factor, Member 14Tnfrsf14 protein, mouseTnfsf14 protein, mouseTumor Necrosis Factor Ligand Superfamily Member 14Viral Envelope Proteinscorneal scarringeye diseaseslatencyocularreactivationvirus replication

Identifiers

PMID30282707
PMCPMC6258941
OpenAlexW2895365534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.